Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• AMTD IDEA Group (NYSE:AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
• Applied DNA Sciences, Inc. (NASDAQ:APDN) gained 166% to $1.8801 after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus.
• ECMOHO Limited (NASDAQ:MOHO) jumped 117% to $0.2528.
• Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPB) rose 56.2% to $75.00 after jumping 187% on Monday.
• 36Kr Holdings Inc. (NASDAQ:KRKR) rose 51% to $1.92 after surging over 10% on Monday.
• Berkshire Grey, Inc. (NASDAQ:BGRY) jumped 39% to $2.4900 after the company announced an expansion of its relationship with FedEx. The company has also granted FedEx a warrant to purchase common stock which vests incrementally.
• Locafy Limited (NASDAQ:LCFY) rose 27.4% to $0.50. Locafy recently announced preliminary unaudited revenue for the financial year ended June 30.
• Sientra, Inc. (NASDAQ:SIEN) gained 26.8% to $1.1817.
• Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) jumped 25.6% to $3.48.
• Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) gained 25.5% to $15.63 as the company posted a narrower-than-expected Q2 loss.
• Nutex Health, Inc. (NASDAQ:NUTX) rose 25% to $3.60.
• Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) rose 23.8% to $3.43.
• Transocean Ltd. (NYSE:RIG) shares rose 23% to $3.96 after the company posted a narrower Q2 loss and announced $321 million contract for ultra-deepwater drillship deepwater conqueror.
• L&F Acquisition Corp. (NASDAQ:LNFA) shares climbed 22% to $13.02.
• Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 21.4% to $2.4286 after FF Top Holding and the company executed a non-binding term sheet for a proposed convertible term loan facility up to $600 million.
• Moxian (BVI) Inc (NASDAQ:MOXC) gained 21.3% to $1.2129.
• Aclarion, Inc. (NASDAQ:ACON) rose 21% to $1.1505.
• Diebold Nixdorf, Incorporated (NYSE:DBD) surged 20.2% to $3.99 following upbeat Q2 earnings.
• Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 19.5% to $2.25 after dropping around 7% on Monday.
• Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) gained 18.3% to $4.83. Quoin Pharmaceuticals recently announced receipt of constructive scientific advice from EMA for QRX003 development in Europe.
• Vroom, Inc. (NASDAQ:VRM) jumped 18% to $1.7200.
• Harsco Corporation (NYSE:HSC) gained 15.6% to $5.55 following Q2 earnings.
• SunPower Corporation (NASDAQ:SPWR) rose 15.2% to $22.84 after the company reported better-than-expected Q2 sales results.
• Renovacor, Inc. (NYSE:RCOR) surged 15.1% to $2.06.
• Microvast Holdings, Inc. (NASDAQ:MVST) gained 15% to $3.06.
• Uber Technologies, Inc. (NYSE:UBER) jumped 14.8% to $28.25 after the company reported better-than-expected Q2 sales results and reported gross bookings up 33% year over year.
• Repligen Corporation (NASDAQ:RGEN) surged 14.6% to $243.65 after the company reported better-than-expected Q2 results and raised FY22 guidance.
• Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) jumped 14.4% to $8.25. Lindblad Expeditions recently reported worse-than-expected Q2 EPS results.
• Ostin Technology Group Co., Ltd. (NASDAQ:OST) rose 14.3% to $2.0108 after gaining 6% on Monday.
• TravelCenters of America Inc. (NASDAQ:TA) jumped 14.1% to $48.44 after the company reported better-than-expected Q2 sales.
• Root, Inc. (NASDAQ:ROOT) gained 13.3% to $1.19.
• Virax Biolabs Group Limited (NASDAQ:VRAX) rose 13.1% to $13.40. Virax Biolabs shares jumped 119% on Monday after New York City on Saturday declared monkeypox a public health emergency, which has lifted monkeypox-related stocks.
• American Rebel Holdings, Inc. (NASDAQ:AREB) rose 13% to $0.6749 after dipping around 22% on Monday.
• Sunworks, Inc. (NASDAQ:SUNW) gained 13% to $2.4400.
• Performance Shipping Inc. (NASDAQ:PSHG) rose 12.3% to $0.4049 after jumping over 30% on Monday. Performance Shipping recently entered into a time charter contract with Teekay Chartering Limited, with a gross charter rate of $23,000 per day for a period of roughly 24 months.
• Lyft, Inc. (NASDAQ:LYFT) gained 11.7% to $15.53 in sympathy with Uber, which reported better-than-expected Q2 earnings results and announced that gross booking volume increased year over year.
• Pinterest, Inc. (NYSE:PINS) rose 11.5% to $22.33 after Elliott Investment Management announced they are now Pinterest's largest investor. The company also reported Q2 financial results and issued Q3 guidance.
• Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) gained 11.4% to $7.38 after the company reported upbeat quarterly earnings and said its Clio Subsidiary entered an agreement for the sale of its interests in five wireless partnerships to Verizon for $490 million.
• JAKKS Pacific, Inc. (NASDAQ:JAKK) gained 10.7% to $24.51.
• ZoomInfo Technologies Inc. (NASDAQ:ZI) rose 10.6% to $41.73 as the company reported better-than-expected results for its second quarter and also raised its revenue guidance for FY22.
• Performance Shipping Inc. (NASDAQ:PSHG) gained 10.2% to $0.3968 after jumping more than 30% on Monday.
• Berkeley Lights, Inc. (NASDAQ:BLI) jumped 9% to $4.9150.
• So-Young International Inc.. (NASDAQ:SY) rose 6.5% to $0.8511.
• Cryptyde, Inc. (NASDAQ:TYDE) rose 5.6% to $1.1409. Cryptyde, Inc. and Argo Energy recently announced Energy Program Development Agreement.
• Conformis, Inc. (NASDAQ:CFMS) rose 5% to $0.2678. Conformis entered into a multi-year agreement with Vizient Inc to offer personalized orthopedic implants to Vizient's membership of healthcare facilities.

Losers

• Ontrak, Inc. (NASDAQ:OTRK) shares fell 44.3% to $0.7520 after the company announced a registered direct offering for aggregate gross proceeds of $4 million. The company is scheduled to report Q2 results on August 9.
• Mobile Global Esports Inc. (NASDAQ:MGAM) shares fell 37.1% to $8.17 after jumping 16% on Monday.
• Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) dropped 30.2% to $6.33 after the company posted a wider Q2 loss.
• FAT Brands Inc. (NASDAQ:FATBB) fell 30% to $10.50. The company recently posted a Q2 net loss of $8.2 million or $0.50 per share.
• DZS Inc. (NASDAQ:DZSI) fell 23% to $15.06 after the company reported worse-than-expected Q2 results.
• FiscalNote Holdings Inc. (NYSE:NOTE) shares fell 17.1% to $7.05. FiscalNote completed acquisition of Aicel Technologies.
• Syneos Health, Inc. (NASDAQ:SYNH) dipped 16.8% to $65.82 as the company lowered its FY22 guidance.
• Better Therapeutics, Inc. (NASDAQ:BTTX) shares declined 16.6% to $2.31. Better Therapeutics recently completed its clinical trial for BT-001, an investigational prescription digital therapeutic that is designed to use nCBT to treat type 2 diabetes.
• TimkenSteel Corporation (NYSE:TMST) fell 16.4% to $16.49 after KeyBanc downgraded the stock from Overweight to Sector Weight.
• Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) dropped 15.7% to $3.2779.
• Aileron Therapeutics, Inc. (NASDAQ:ALRN) dipped 14.9% to $0.1363.
• Daseke, Inc. (NASDAQ:DSKE) declined 14.6% to $7.34 following Q2 results.
• Titan International, Inc. (NYSE:TWI) fell 14.4% to $14.52 following weak quarterly sales.
• Oatly Group AB (NASDAQ:OTLY) dipped 14.4% to $3.3539 after the company reported worse-than-expected Q2 sales and issued FY22 sales guidance below estimates.
• Enhabit, Inc. (NYSE:EHAB) dropped 13.9% to $15.47. Enhabit reported a 6.3% year-over-year decline in net service revenue.
• Otonomy, Inc. (NASDAQ:OTIC) fell 13.8% to $0.2510. Otonomy recently announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints.
• Kopin Corporation (NASDAQ:KOPN) declined 13.7% to $1.63 as the company reported second-quarter FY22 revenue growth of 20% year-on-year of $11.9 million, missing the consensus of $12.6 million.
• Celyad Oncology SA (NASDAQ:CYAD) fell 13.7% to $2.1125. Calyad Oncology recently said that the FDA has lifted the clinical hold on the company's CYAD-101-002 Phase 1b trial after the company made changes to the eligibility criteria for the trial.
• Emergent BioSolutions Inc. (NYSE:EBS) dropped 13.1% to $29.76 following downbeat quarterly results.
• Astec Industries, Inc. (NASDAQ:ASTE) fell 11.4% to $43.38 after reporting a decline in quarterly earnings.
• Woodward, Inc. (NASDAQ:WWD) dipped 10.2% to $94.12 after the company issued FY22 guidance below estimates. The company said its Q3 profitability was impacted by labor and material inflation as well as global supply chain and labor disruption.
• Molson Coors Beverage Company (NYSE:TAP) fell 10.2% to $53.57 after the company reported worse-than-expected Q2 sales results.
• Matson, Inc. (NYSE:MATX) fell 9.9% to $82.26 following Q2 results.
• Avis Budget Group, Inc. (NASDAQ:CAR) dropped 9.1% to $164.66. Avis Budget reported better-than-expected Q2 EPS and sales results.
• Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) fell 8.8% to $0.6799 after gaining around 18% on Monday.
• Zebra Technologies Corporation (NASDAQ:ZBRA) dropped 8.8% to $326.73 after the company issued Q3 guidance below estimates.
• Arconic Corporation (NYSE:ARNC) fell 8.6% to $27.82 as the company lowered its FY22 top-line outlook.
• Sealed Air Corporation (NYSE:SEE) fell 8.4% to $56.31 following Q2 results.
• Credit Acceptance Corporation (NASDAQ:CACC) dropped 8.3% to $533.62 after reporting Q2 results.
• Credit Suisse Group AG (NYSE:CS) fell 5.5% to $5.45. Credit Suisse Group recently reported quarterly losses of 62 cents per share.